Streamlining Mesenchymal Stem Cell (MSC) Expansion

The demand for mesenchymal stem cells (MSCs) in cell and gene therapies is on the rise, but producing them at scale is a challenge. MSC expansion can be complex, time-consuming, and labor-intensive, demanding strict regulatory compliance.

In a recent webinar, Terumo Blood and Cell Technologies introduced Quantum Flex™, a functionally closed, GMP-compliant system designed to streamline MSC expansion. With customizable protocols, Quantum Flex allows for seamless scaling from small to large bioreactors, reducing production variability through in-process monitoring. The system boasts 90% seeding efficiency and maintains optimal growth conditions, ensuring high yields and consistent quality of MSCs.

Read the full article to learn more about the future of MSC expansion.